Printer Friendly

Browse Colorectal cancer topic

Development and progression subtopic



1-76 out of 76 article(s)
Title Author Type Date Words
eFFECTOR Therapeutics to Collaborate with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate a Novel Immuno-oncology Combination in Microsatellite Stable Colorectal Cancer. Jun 20, 2017 1506
New method reduces adverse effects of rectal cancer treatment. Mar 31, 2017 459
High tumor stroma proportion is a worse prognostic factor in colorectal cancer. Flam, Josipa; Gugic, Damir; Bensic, Mirta; Tomic, Snjezana; Rajc, Jasmina Report Mar 1, 2017 3728
Effect of human amniotic membrane on prevention of colorectal anastomosis leakage in cases with neoadjuvant radiotherapy: an experimental animal study. Moslemi, Sam; Joraghi, Sajjad Ahmadi; Roshanravan, Reza; Ghahramani, Leila; Mohammadianpanah, Mohamm Report Nov 1, 2016 3300
New Retrospective Analyses Confirm Vectibix (Panitumumab) Treatment Provided Survival Benefit Over Chemotherapy With Or Without Bevacizumab In Metastatic Colorectal Cancer Patients With Tumors Of Left-Sided Origin. Oct 10, 2016 6073
Germany : Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. Clinical report Jul 2, 2016 556
Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. Clinical report Jul 1, 2016 1788
Results of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer. Clinical report Jul 1, 2016 1792
LGALS3 and AXIN1 gene variants playing role in the Wnt/[beta]-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer. Korkmaz, Gurbet; Horozoglu, Cem; Arikan, Soykan; Gural, Zeynep; Saglam, Esra Kaytan; Turan, Saime; O May 1, 2016 5102
Potent anti-angiogenic and cytotoxic effect of conferone on human colorectal adenocarcinoma HT-29 cells. Cheraghi, Omid; Dehghan, Gholamreza; Mahdavi, Majid; Rahbarghazi, Reza; Rezabakhsh, Aysa; Charoudeh, Report Apr 15, 2016 4603
Colorectal cancer in India: an iceberg analysis from north India. Narang, Vikram; Puri, Namrata; Singh, Aminder; Sood, Neena; Malhotras, Vineeta Report Jan 11, 2016 5147
Inflammation drives colorectal cancer metastasis. Brief article Jan 1, 2016 230
Transperineal approach to complex rectourinary fistulae. Tran, Henry; Flannigan, Ryan; Rapoport, Daniel Report Nov 1, 2015 2879
Colorectal cancer screening challenges in West Virginia. Report Nov 1, 2015 1364
Short term outcome and predictors of response to neoadjuvant treatment in rectal cancer. Oct 31, 2015 2335
The effects of NDRG2 overexpression on cell proliferation and invasiveness of SW48 colorectal cancer cell line. Golestan, Ali; Mojtahedi, Zahra; Ghalamfarsa, Ghasem; Hamidinia, Maryam; Takhshid, Mohammad Ali Report Sep 1, 2015 5135
K-ras mutation in colorectal cancer, a report from southern Iran. Omidifar, Navid; Geramizadeh, Bita; Mirzai, Mitra Report Sep 1, 2015 3589
FiBRO: Fibroblasts in the Biology of Rectal Cancer Progression. Jun 26, 2015 368
Caris Life Sciences Presents New Tumor Profiling Research Providing Insights into the Clinical Benefit of Targeted Therapies for Colorectal Cancer Treatment-Resistant Subgroups. May 31, 2015 1066
Visfatin proliferative effect on HCT-116 colorectal cancer cell line. Ghaemmaghami, Sara; Hedayati, Mehdi; Mohaddes, Seyed Mojtaba; Mohammadi, Masumeh Gorgian; Rahmati, M Report Jun 20, 2014 3410
IntegraGen partners with New EPOC Study team on metastatic colorectal cancer biomarker validation. Jan 15, 2014 170
Analysis Published In New England Journal of Medicine Highlights Discovery Of New Predictive Biomarkers For Vectibix (Panitumumab). Sep 11, 2013 2723
Trovagene collaborates with USC in clinical study evaluating cancer monitoring technology. Clinical report Sep 6, 2013 850
Trovagene, University of Southern California join hands on cancer monitoring study. Sep 6, 2013 164
Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting. May 21, 2013 1726
Germany : Bayer s Stivarga (regorafenib) Tablets Approved in Japan for the Treatment of Advanced or Recurrent Colorectal Cancer. Mar 26, 2013 372
Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology. Matkowskyj, Kristina A.; Chen, Zongming E.; Rao, M. Sambasiva; Yang, Guang-Yu Report Mar 1, 2013 10958
Small cell neuroendocrine carcinoma of rectum with associated paraneoplastic syndrome: a case report. Vergeli-Rojas, Jeannette A.; Santiago-Caraballo, Dania L.; Caceres-Perkins, William; Magno-Pagatzart Report Mar 1, 2013 1482
Urothelial cancer and the diagnosis of subsequent malignancies. Pruthi, Deepak K.; Nugent, Zoann; Czaykowski, Piotr; Demers, Alain A. Report Feb 1, 2013 3954
Protective effects of coffee: National Institutes of Health discovers. Stokel, Kirk Report Sep 1, 2012 5616
Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020. Jul 4, 2012 7537
Adenocarcinoma following urinary diversion. Jian, Peter Yicum; Godoy, Guilherme; Coburn, Michael; Lynch, Garrett; Ro, Jae Y.; Zhai, Qihui "Jim"; Clinical report Apr 1, 2012 2581
Eradication of etiologic factors key to prevention of colorectal cancer. Nov 11, 2011 497
Study by Ocala Oncology/The US Oncology Network Shows Use of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Improves Overall Survival. Sep 28, 2011 1097
Immunohistochemical expression of estrogen and progesterone receptors in human colorectal adenoma and carcinoma using specified automated cellular image analysis system: a clinicopathological study. Qasim, Ban Jumaa; Ali, Hussam Hasson; Hussein, Alaa Ghani Report Sep 1, 2011 4567
Smoking raises risk of breast, colon cancer. Smith, Jennie Jun 1, 2011 631
Nutritional advantages and disadvantages of dietary phytates: a literature review part 2. Connelly, Patrice Jun 1, 2011 4260
The everyday drug that prevents cancer death. Korlov, Edward Report May 1, 2011 4938
The genetic etiology of familial and nonfamilial colorectal cancer. Cherry, Lorraine M. Report Apr 1, 2011 2415
KFSH&RC Identifies Genes Potentially Playing An Important Role in the Progression of Colorectal Carcinoma. Mar 29, 2011 524
Can blueberry extracts halt metabolic syndrome? Parente, Matilde Mar 1, 2011 3878
How curcumin protects against cancer. Borger, J. Everett Report Mar 1, 2011 5056
Cancer biomarkers: surviving the Journey From Bench to Bedside. Rhea, Jeanne M.; Molinaro, Ross J. Mar 1, 2011 6455
Reportlinker Adds Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020. Company overview Oct 14, 2010 5145
Reportlinker Adds Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020. Oct 14, 2010 4546
Reportlinker Adds Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010. Company overview Oct 12, 2010 6920
Two Pivotal Vectibix Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology. Oct 4, 2010 3272
Tonsillar metastasis of signet-ring cell adenocarcinoma of the colon. Park, Kelly K.; Park, Youn W. Case study Aug 1, 2010 1263
Top 20 pharma report. Roth, Gil Y. Company overview Jul 1, 2010 24275
Aeterna Zentaris Reports Final Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine in the Treatment of Advanced Metastatic Colorectal Cancer. Clinical report Jun 8, 2010 1881
Practical and molecular evaluation of colorectal cancer: new roles for the pathologist in the era of targeted therapy. de Hertogh, Gert; Geboes, Karen Paula Report Jun 1, 2010 10322
Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis. Harpaz, Noam; Polydorides, Alexandros D. Disease/Disorder overview Jun 1, 2010 16260
15th Congress of the European Cancer Organization and the 34th European Society for Medical Oncology multidisciplinary congress: GI update. Brown, Vanessa Clinical report Oct 1, 2009 1840
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer. Sep 24, 2009 2243
Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer. Sep 22, 2009 2107
Top 20 pharma report. Roth, Gil Y. Jul 1, 2009 23997
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Nordlinger, Bernard; Van Cutsem, Eric; Gruenberger, Thomas; Glimelius, Bengt; Poston, Graeme; Rougie Reprint Jun 1, 2009 7125
Peculiarities of vascular component of communicative systems in rectal adenomas. Bychkov, Andrey V.; Dorosevich, Alexander E. Report Mar 1, 2009 2616
Chemo offers no reason to skip the flu shot. London, Susan Brief article Feb 15, 2009 242
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting. Clinical report May 16, 2008 1505
KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients. Jan 24, 2008 2040
J Med Sci: Multivariate analysis of prognostic determinants for colorectal cancer patients with high preoperative serum CEA levels: prognostic value of postoperative serum CEA levels. Ma, C.J.; Hsieh, J.S.; Wang, W.M. Abstract Apr 1, 2007 267
Xeloda Meets Primary Endpoint in Multinational Phase III Advanced Colorectal Cancer Study. Dec 11, 2006 893
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer. Sep 27, 2006 1585
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Umetani, Naoyuki; Kim, Joseph; Hiramatsu, Suzanne; Reber, Howard A.; Hines, Oscar J.; Bilchik, Anton Clinical report Jun 1, 2006 4802
Panitumumab found to slow metastatic colorectal cancer. Splete, Heidi May 15, 2006 445
Three-dimensional microarray compared with PCR-single-strand conformation polymorphism analysis/DNA sequencing for mutation analysis of K-ras codons 12 and 13. Maekawa, Masato; Nagaoka, Tomonori; Taniguchi, Terumi; Higashi, Hitomi; Sugimura, Haruhiko; Sugano, Aug 1, 2004 3392
Colectomy in colitis. Brief Article Jan 1, 2004 174
Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Ghilardi, Giorgio; Biondi, Maria Luisa; Erario, Maddalena; Guagnellini, Emma; Scorza, Roberto Nov 1, 2003 2449
Intermittent chemotherapy. (Clinical Capsules). Evans, Jeff Brief Article Apr 1, 2003 148
Cancer in familial polyposis. (Clinical Capsules). Evans, Jeff Brief Article Aug 1, 2002 182
Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Duffy, Michael J. Clinical report Apr 1, 2001 5680
Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes. Miyashiro, Isao; Kuo, Christine; Huynh, Kelly; Iida, Aritoshi; Morton, Donald; Bilchik, Anton; Giuli Mar 1, 2001 5171
K-ras mutation detection by hybridization to a polypyrrole DNA chip. Lopez-Crapez, Evelyne; Livache, Thierry; Marchand, Joseph; Grenieri, Jean Feb 1, 2001 4639
Myelophthisis as a Solitary Manifestation of Failure From Rectal Carcinoma A Batson Phenomenon? Mathew, Paul; Fleming, Declan; Adegboyega, Patrick A. Brief Article Aug 1, 2000 1755
Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Bidart, Jean-Michel; Thuillier, Francois; Augereau, Christine; Chalas, Jacqueline; Daver, Alain; Jac Oct 1, 1999 12398

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters